The FSA Spy market buzz – 2 May 2025
Grayscale’s innovation proxy; Blue Owl is making waves; Lombard Odier and China’s energy transition; UBS and contrarian investing; Janus Henderson and robots; Berkshire Hathaway and much more.
HEAD-TO-HEAD: Allianz versus Invesco
FSA compares two China equity products: the Allianz All China Equity Fund and the Invesco China Equity Fund.
Conclusion
“Both funds have strong teams on the ground, which is essential in the China equity market in general and especially during these turbulent times,” said McDermott.
The Invesco fund has a maximum five-star rating from Morningstar, which evaluates funds based on their past performance, while also taking into account their risk and, increasingly, their fees.
FE Fundinfo awards it three crowns (out of five), which reflects the fund’s to stock-picking, consistency and risk control.
The Allianz fund has yet to be rated by either research firm because of its brief track-record.
“In fact, it is both the long-term performance and the value nature of the Invesco vehicle which makes it a more attractive,” said McDermott.
“We like the fact the managers target companies they feel are undervalued by about 25-30% and hold them with the expectation they will reach fair value over a three to five-year time horizon,” he added.
“It’s a fund we have supported for many years.”
Related Stories
Promoted Content
-
The year of living dangerously for income investors
-
Your Questions Answered by Federated Hermes Impact Opportunities
-
Accessing India’s tech future
-
Healthcare’s innovation shifts into high gear
-
Who’s afraid of higher interest rates?
-
China’s post-pandemic growth gathers pace
-
How ETFs offer an active way to drive sustainable returns
-
Conditions in the high yield market
-
Nuveen broadens income sources via private capital and real assets
-
Federated Hermes SDG Engagement Equity: 2021 H1 Report
